Compare INGR & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INGR | CRL |
|---|---|---|
| Founded | 1906 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.5B |
| IPO Year | 1997 | 1999 |
| Metric | INGR | CRL |
|---|---|---|
| Price | $114.03 | $176.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 12 |
| Target Price | $132.71 | ★ $198.27 |
| AVG Volume (30 Days) | 494.1K | ★ 729.4K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.91% | N/A |
| EPS Growth | ★ 15.14 | N/A |
| EPS | ★ 11.18 | N/A |
| Revenue | ★ $7,219,000,000.00 | $1,857,601,000.00 |
| Revenue This Year | $3.93 | $0.19 |
| Revenue Next Year | $2.79 | $2.98 |
| P/E Ratio | $10.08 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $102.31 | $99.80 |
| 52 Week High | $141.78 | $228.88 |
| Indicator | INGR | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 52.30 | 57.09 |
| Support Level | $109.00 | $147.06 |
| Resistance Level | $114.10 | $182.76 |
| Average True Range (ATR) | 1.83 | 7.22 |
| MACD | 0.22 | 1.83 |
| Stochastic Oscillator | 53.23 | 76.69 |
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.